Controlled randomized clinical trials;L'essai clinique contrôlé randomisé

Bulletin de l'Academie Nationale de Medecine

Volumn 191, Issue 4-5, 2007, Pages 739-758

  Jaillon, Patrice ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Biomedical research; Randomized controlled trials

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSSOVER PROCEDURE; EUROPE; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HISTORY; HUMAN; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; EUROPE; EVIDENCE-BASED MEDICINE; HISTORY, 16TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 39549103462     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33007-9     Document Type: Article

References (24)

1. LIND J. - A treatise of the scurvy in three parts. Containing an inquiry into the nature causes and cure of that disease, together with a critical and chronological view of what has been published on the subject. A. Millar, London, 1753.
2. MARTINI E. - Comment Lind n'a pas découvert le traitement contre le scorbut. Histoires des Sciences Médicales, 2005, tome 39, n° 1, 79-92.
3. LOUIS P.C. A. -Recherches sur les effets de la saignée. 1835, Paris, De Mignaret Editeur.
4. Medical Research Council -Streptomycin treatment of pulmonary tuberculosis. Brit. Med. J., 1948, 2, 769-782
5. BOISSEL J.P. -Impact of randomized clinical trials on medical practices. Control. Clin. Trials, 1989, 10, 120 S-134 S.
6. BOUVENOT G. et VRAY M. -Essais cliniques. Théorie, pratique et critique, p. XV 4èmc édition. Médecine Sciences Flammarion, Paris, 2006.
7. Évidence -Based Medicine Working Group -Evidence -based medicine. A new approach to teaching the practice of medicine. J.A.M.A., 1992, 268, 2420-2425
8. COOK DJ., GUYATT G.H., LAUPACIS A., SACKETT D., GOLDBERG R.J. -Clinical recommendations using levels of evidence for antithrombotic agents. Chest, 1995, 108, 227 S-230 S.
9. [9] RUBERMAN W., WEINBLATT E., GOLDBERG J.D., FRANK C.W., SHAPIRO S. -Ventricular premature beats and mortality after myocardial infarction. N. Engl. J. Med., 1977, 297, 750-757 (Pubitemid 8201636)
10. Moss AJ., DAVIS H.T., DECAMILLA J., BAYER L.W. -Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation, 1978, 60, 998-1003.
11. BIGGER J.T JR, FLEISS J.L., KLEIGER K., MILLER J.P., ROLNITZKY L.M. and The Multicenter Post Infarction Research Group -The relationship between ventricular arrythmias, left ventricular dysfunction and mortality in the two years after myocardial infarction. Circulation, 1984, 69, 250-258
12. MUKHARJI J., RUDE R.E., POOLE W.K., GUSTAFSON N., THOMAS LJ. JR, STRAUSS H.W. et al- The Milis Study Group Risk factors for sudden death after acute myocardial infarction : two-year follow-up. Am. J. Cardiol., 1984, 54, 31-36
13. The Cardiac Arrhythmia Pilot Study (CAPS) investigators -Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction : The CAPS. Am. J. Cardiol., 1988, 61, 501-509
14. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators -Preliminary report : Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med., 1989, 327, 406-412
15. ECHT D., LIEBSON P.R., BRENT MICHELL L., PETERS R.W., OBIAS-MANNO D., BARKER A.H. et al- Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl. J. Med, 1991, 324, 781-788
16. CIBIS II investigators and committees -• The Cardiac insufficiency Bisoprolol Study II (CIBIS II). Lancet, 1999, 353, 9-13.
17. HANSSON L., HEDNER T., DAHLOF B. -Prospective Randomized Open Blinded-Endpoint (PROBE) Study : a novel design for intervention trials. Blood Pressure, 1992, 1, 113-119
18. [18] CAPRIE Steering committee -A randomized,blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996, 348, 1329-1339 (Pubitemid 26383772)
19. [19] The FIELD Study Investigators -Effect of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD Study) : randomised controlled trial. Lancet, 2005, 366, 1849-1861 (Pubitemid 41690113)
20. BARRETT-CONNOR E., MOSCA L., COLLINS P., GEIGER M.J., GRADY D., KORNITZER M. et al. for the Raloxifene Use for the Heart (RUTH) Trial investigators. -Effects of Raloxifene on cardiovascular events and breast cancer in postmenopausal women. N. Engl. J. Med., 2006,355, 125-137
21. [21] CRASH Trial collaborators -Effect of intravenous corticosteroids on death within 14daysin 10 008 adults with clinically significant head injury (MRC CRASH trial) : randomised placebocontrolled trial. Lancet, 2004, 364, 1321-1328 (Pubitemid 39335823)
22. The Atrial Fibrillation Follow-up investigation of Rhythm Management (AFFIRM) investigators -A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl. J. Med., 2002, 347, 1825-1833
23. The Antihypertensive and lipid-lowering treatment to prevent Heart Attack Trial (ALLHAT) - Major cardiovascular events in hypertensive patients randomized to doxasocin vs chlorthalidone. J.A.M.A., 2000, 283, 1967-1975
24. [24] The Antihypertensive and lipid-lowering treatment to prevent Heart Attack Trial (ALLHAT) - Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. J.A.M.A., 2002, 288, 2981-2997 (Pubitemid 35471160)